Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2014
09/10/2014EP2773346A1 Pharmaceutical compositions of hydrophobic camptothecin derivatives
09/10/2014EP2773345A1 Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
09/10/2014EP2773344A1 Delivery systems for improving oral bioavailability of fenobam, its hydrates, and salts
09/10/2014EP2773343A2 Cosmetic use of n-heteroarylbisamide analogs and related compounds
09/10/2014EP2773342A1 Compositions useful for the treatment of viral diseases
09/10/2014EP2773341A2 Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders
09/10/2014EP2773340A1 Use of neu1 sialidase inhibitors in the treatment of cancer
09/10/2014EP2773339A1 Composition for improving neuropsychological test battery score
09/10/2014EP2773338A1 Improving recognition
09/10/2014EP2773337A1 Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitors
09/10/2014EP2773336A1 Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent
09/10/2014EP2773335A1 Neprilysin inhibitors
09/10/2014EP2773334A2 Composition with sustained antimicrobial activity
09/10/2014EP2773333A1 Dermal delivery compositions and methods
09/10/2014EP2773329A1 Pharmaceutical compositions comprising sevelamer
09/10/2014EP2773325A1 Liposomal corticosteroids for treatment of inflammatory disorders in humans
09/10/2014EP2773322A1 Methods for treating cancers using oral formulations of cytidine analogs
09/10/2014EP2773215A2 Compounds with nematicidal activity
09/10/2014EP2773212A1 Methods and compositions for treatment of autism
09/09/2014USRE45128 Cephalotaxane derivatives and their processes of preparation and purification
09/09/2014US8829264 Methods and compositions for RNA interference
09/09/2014US8829242 Amide derivatives of valproic acid and uses thereof
09/09/2014US8829210 Process for preparing docetaxel and its hydrate
09/09/2014US8829200 Benzimidazole inhibitors of leukotriene production
09/09/2014US8829199 Aminopyrazole derivative
09/09/2014US8829198 Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
09/09/2014US8829196 TRPA1 antagonists
09/09/2014US8829195 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
09/09/2014US8829194 Crystalline forms of the sodium salt of (4-{4-[5-(6-trifluoromethyl-pyridin-3-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid
09/09/2014US8829193 PIM kinase inhibitors and methods of their use
09/09/2014US8829190 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
09/09/2014US8829189 Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
09/09/2014US8829185 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
09/09/2014US8829180 Method of purifying a low molecular weight hyaluronic acid or cationized hyaluronic acid via precipitation from aqueous solution by addition of alcohol or acetone followed by ph adjustment
09/09/2014US8829167 Foliamangiferosides, preparation method and use thereof
09/09/2014US8829158 Peptides, derivatives and analogs thereof, and methods of using same
09/09/2014US8829058 Compounds and method for reducing uric acid
09/09/2014US8829057 AMPK activating agent
09/09/2014US8829056 Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl) cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods
09/09/2014US8829054 Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
09/09/2014US8829053 Biocidal compositions and methods of using the same
09/09/2014US8829052 Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK
09/09/2014US8829051 Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux
09/09/2014US8829050 Compositions and methods for reducing body fat
09/09/2014US8829049 Medicinal composition intended for the treatment of erectile dysfunction in mammals and use of the composition
09/09/2014US8829048 Use of highly concentrated compositions of selected n-3 fatty acids for the treatment of central nervous system disturbances
09/09/2014US8829047 Methods of controlling venous irritation associated with the treatment of a cardiac disorder
09/09/2014US8829046 3-methanesulfonylpropionitrile for treating inflammation and pain
09/09/2014US8829044 Stabilized vitamin C derivatives having a peptide molecule, preparation method thereof, and composition containing the same
09/09/2014US8829043 Oligome-cannabinoid conjugates
09/09/2014US8829041 Cyclopropyl amine derivatives
09/09/2014US8829040 (aza)indole derivative and use thereof for medical purposes
09/09/2014US8829039 Dihydroindolinone derivatives
09/09/2014US8829037 Optical correction
09/09/2014US8829036 Heterocyclic aspartyl protease inhibitors
09/09/2014US8829035 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
09/09/2014US8829034 Compounds which modulate the CB2 receptor
09/09/2014US8829031 Indole derivative modulators of the alpha 7 nAChR
09/09/2014US8829030 Compounds and methods for the treatment or prevention of Flavivirus infections
09/09/2014US8829029 Dual modulators of 5HT2A and D3 receptors
09/09/2014US8829028 5-HT4 receptor antagonists for the treatment of heart failure
09/09/2014US8829027 Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
09/09/2014US8829026 Sulfamoyl benzoic acid heterobicyclic derivatives as TRPM8 antagonists
09/09/2014US8829025 Anti-cancer compounds
09/09/2014US8829024 Combination steroid and glucocorticoid receptor antagonist therapy
09/09/2014US8829023 Process for obtaining compounds derived from tetrahydro-β-carboline
09/09/2014US8829022 N-substituted indenoisoquinolines and syntheses thereof
09/09/2014US8829021 Treatment of pediatric tumors
09/09/2014US8829020 Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
09/09/2014US8829019 Stable tablet containing 4,5-epoxymorphinan derivative
09/09/2014US8829018 Method of restoring the incretin effect
09/09/2014US8829017 Methods of treating traveler's diarrhea and hepatic encephalopathy
09/09/2014US8829016 Triazole compounds as potential anti-inflammatory agents
09/09/2014US8829015 Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
09/09/2014US8829014 Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers
09/09/2014US8829013 Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
09/09/2014US8829011 2-aminopyrimidine compounds as serotonin receptor modulators
09/09/2014US8829010 Pyrazolo[3,4-d]pyrimidine compounds and their use as PDE2 inhibitors and/or CYP3A4 inhibitors
09/09/2014US8829009 Substituted 2-amino-3-(sulfonyl)pyrazolo[1,5-a]pyrimidines - serotonin 5-HT6 receptor antagonists, method for use thereof
09/09/2014US8829008 Organic compounds
09/09/2014US8829006 Compounds
09/09/2014US8829005 Ophthalmic formulations of cetirizine and methods of use
09/09/2014US8829004 Method for inducing tumor apoptosis by increasing nitric oxide levels
09/09/2014US8829003 Compounds for treating proliferative disorders
09/09/2014US8829001 Dopamine D3 receptor ligands and preparation and medical uses of the same
09/09/2014US8829000 Substituted imidazo[1,5-A]quinoxalines as phosphodiesterase 9 inhibitors
09/09/2014US8828999 Pyrimidine compounds and their uses
09/09/2014US8828998 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
09/09/2014US8828997 2,3-dihydro-1H-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof
09/09/2014US8828996 Morpholine-spirocyclic piperidine amides as modulators of ion channels
09/09/2014US8828995 Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
09/09/2014US8828994 Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
09/09/2014US8828993 Psychotropic agents having glutamate NMDA activity
09/09/2014US8828992 Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating Parkinson's disease using the same
09/09/2014US8828991 Azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
09/09/2014US8828990 N-7 substituted purine and pyrazolopyrimine compounds, compositions and methods of use
09/09/2014US8828989 Oxy-cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[E]azulenes as V1A antagonists
09/09/2014US8828988 8-AZA tetracycline compounds
09/09/2014US8828987 Pyridine amide derivatives as EP4 receptor antagonists
09/09/2014US8828986 Antiviral compounds
1 ... 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 ... 7860